Evgen Pharma plc, of Cheshire, U.K., appointed Barry Clare interim executive chair of its board until a new CEO is named.

Hemostemix Inc., of Calgary, Alberta, appointed David H. Tsubouchi to its board of advisers.

Intellia Therapeutics Inc., of Cambridge, Mass., appointed David Lebwohl executive vice president and chief medical officer.

Syncona Ltd., of London, appointed Danny Bar-Zohar partner.

No Comments